Novel Phenanthraquinone Derivative from Antarctic Lichen Umbilicaria antarctica Exhibits Apoptotic Activity in Triple-Negative Breast Cancer
Abstract
Triple-negative breast cancer (TNBC) is one of the most challenging malignancies in modern drug development, as its poor prognosis and limited therapeutic options create an urgent demand for innovative treatments. To address this, Antarctic lichensknown for their diverse pharmacological activities, including anticancer, antioxidant, antimicrobial, and anti-inflammatory effectswere selected as a natural source for potential lead compounds. Extensive chemical analysis of Umbilicaria antarctica (L.) Ach., a lichen species prevalent on Antarctic rocky terrains, successfully led to the isolation of new compounds, carboxygyrophoric acid (1) and umbiliquinone (2). The chemical structures of 1 and 2 were determined through extensive spectroscopic methods and ECD calculations. All compounds (1-15) were evaluated for their cytotoxicity against SK-OV-3, MDA-MB-231, and A549 cancer cell lines. The new compound, umbiliquinone (2), exhibited statistically significant cytotoxicity in all three cell lines, notably including the TNBC cell lines MDA-MB-231. It exhibited IC50 values between 28 and 57 μM across these cell lines. Combined with the observed activity of compounds 9, 11, 13, 14, and 15, these findings strengthen the evidence for their development as potential agents against TNBC. Molecular dynamics (MD) simulations were further conducted to investigate the interactions between compounds 2 and 9 and Bcl-2, an antiapoptotic protein, to gain mechanistic insight into their potential…
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.